Skip to main content
. 2024 Mar 11;2024(1):16. doi: 10.5339/qmj.2024.16

Table 3.

Comparison between the two drugs at the baseline and the end of the study.

Mean rank P-value *
Hb at baseline (first month)
Aranesp, N = 67 68.4 0.156
Eprex, N = 60 59.1
Hb at the end of the study period (sixth month)
Aranesp, N = 67 80.6 < 0.001
Eprex, N = 60 45.4
*

P-values were obtained by the Mann-Whitney U test.